Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma

NCT00567476 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Omalizumab
DRUG: Inhaled corticosteroids (ICS)
DRUG: Long-acting beta 2-adrenergic agonist (LABA)
DRUG: Short-acting beta 2-adrenergic agonist (SABA)

Sponsor

Novartis